Buy ACE-031 Peptide

ACE-031 is a peptide that promotes muscle growth by inhibiting myostatin and other negative regulators of muscle mass. It is being developed as a therapeutic protein for the treatment of Duchenne Muscular Dystrophy (DMD).

Twin Pack Saver

ACE-031 Pre-Mixed Pen 1mg
£99.96 – £269.89 Select options This product has multiple variants. The options may be chosen on the product page
SALE

ACE-031 Peptide Vial 1mg
£82.77 – £91.66 Select options This product has multiple variants. The options may be chosen on the product page
SALE

ACE-031 Nasal Spray
£89.57 – £174.89 Select options This product has multiple variants. The options may be chosen on the product page

Which ACE-031 Product is Right for You?

PharmaGrade Store United States provides a variety of ACE-031 products to meet your needs, based on your research objectives.:

ACE-031 Peptide Vial – Your selected peptide, lyophilized and packaged in a glass vial for intramuscular injection into study participants’ muscles. Please note you also require bacteriostatic water when reconstituting your peptide.
Buy ACE-031 1mg vials here.
ACE-031 Nasal Spray – a ready to use peptide solution ready for administration via the nose of of clinical research subjects. Choose from 15ml or 30ml nasal sprays here.
ACE-031 Pre-Mixed Peptide Pen – Pen kits and cartridges come ready to use with pre-mixed ACE-031 peptide and bacteriostatic water. Buy ACE-031 1mg Pre-Mixed Pen peptide here from Pharmagrade Store

Buy ACE-031 United States for Research Purposes

ACE-031 is a synthetic peptide designed to promote muscle growth by inhibiting myostatin, a protein that naturally limits muscle development [1].

By binding to myostatin and other negative regulators, ACE-031 effectively enhances muscle mass, making it a promising candidate for the treatment of muscle-wasting conditions such as Duchenne Muscular Dystrophy (DMD) which can cause severe muscle loss [2].

United States Research indicates that ACE-031 has demonstrated a favourable safety profile, with studies reporting it as generally well-tolerated. This investigational therapeutic is being developed to offer new hope for patients with DMD, aiming to improve muscle strength and overall quality of life by counteracting muscle degeneration.

Benefits of ACE-031 Peptide United States

United States Clinical studies have demonstrated that ACE-031 peptide could have the following potential benefits:

ACE-031 promotes muscle growth – muscle mass is enhanced by ACE-031 inhibiting myostatin, a protein that restricts skeletal muscle development, leading to increased muscle size and strength [1].
ACE-031 improves muscle strength – Subjects of clinical trials using ACE-031 may experience increased muscle tissue strength, which can aid in daily activities, improve mobility and physical performance.
Potential applications for DMD – ACE-031 is being tested for the treatment of Duchenne Muscular Dystrophy (DMD) and other muscle-wasting conditions, potentially improving patient outcomes and quality of life [2].

Scientific Research ACE-031 United States

Research on ACE-031 peptide has primarily focused on its development as a therapeutic agent for muscle-wasting diseases, notably Duchenne Muscular Dystrophy (DMD) [3].

Recent studies have demonstrated its ability to promote muscle growth by inhibiting myostatin, a protein that limits muscle development. Findings indicate that ACE-031 is generally well-tolerated, showcasing a favourable safety profile. Further research has highlighted its efficacy in enhancing muscle mass and strength, offering promising potential for improving patient outcomes. This research underscores the peptide’s novel mechanism of action, emphasizing its role as a pioneering approach in advancing treatment options for muscle degeneration.

Buy ACE-031 Nasal Spray United States highest quality peptides from PharmaGrade.Store online for research use.

Frequently Asked Questions about ACE-031 Peptide United States

What are the effects of overexpressing myostatin inhibitors?

Overexpressing myostatin inhibitors can lead to increased muscle mass but may decrease muscle quality, meaning the strength-to-mass ratio might be reduced. Additionally, myostatin inhibition can affect bone metabolism, potentially enhancing bone mineral density and regeneration offering hope for those suffering with osteoporosis. However, there are risks associated with overexpression, such as an increased chance of tendon rupture and potential heart issues due to inflamed cardiac tissue [4].

Is ACE-031 considered safe?

ACE-031 has generally been considered well-tolerated during studies into human application, indicating a favourable safety profile. However, as with any investigational therapeutic, the safety and efficacy are subject to ongoing research and clinical trials to fully understand its potential side effects and long-term impact before it can be approved by the FDA [5]. Common adverse effects associated with injectable medicine may occur such as irritation around the injection site.

Is ACE-031 currently approved for the treatment of DMD?

ACE-031 supplement is not currently approved for the treatment of Duchenne Muscular Dystrophy (DMD). It remains an investigational drug or research product, and while it has shown promise in early studies, it would need to undergo further development clinical trials and regulatory review before potentially receiving approval from the drug administration agency for medical use.

Are the effects of ACE-031 similar to growth hormone releasing peptides?

ACE-031 and growth hormone-releasing peptides (GHRPs) both aim to enhance the growth of muscle cells and lean body mass, but they operate through different mechanisms. ACE-031 is a myostatin inhibitor, which works by blocking myostatin, a protein that limits skeletal muscle growth, thereby allowing for increased muscle mass and strength. On the other hand, GHRPs stimulate the release of growth hormone from the pituitary gland, which can lead to muscle growth, improved bone density, fat loss, endurance, and improved recovery.

While both can contribute to muscle development, ACE-031 specifically targets the myostatin pathway, whereas GHRPs influence the body’s growth hormone levels. Their effects might overlap in terms of muscle function and growth, but they achieve these outcomes through distinct biological processes.

Blogs:

Unlocking the Power of GDF-8 Myostatin: Benefits and Uses

This blog explores the benefits and uses of GDF-8 Myostatin, a protein that regulates muscle growth. It highlights how inhibiting Myostatin can enhance muscle size, strength, and recovery, making it appealing to fitness enthusiasts and bodybuilders. The article delves into the protein’s mechanism, its role in muscle regulation, and the potential of Myostatin inhibitors to revolutionize muscle-building practices.

Are Peptides Safe? A Close Look for Fitness Enthusiasts and Researchers

This blog explains how peptides can enhance muscle growth, recovery, treat specific ailments and have other health benefits. However, safety concerns include potential side effects, quality control issues, and the need for more research on long-term effects. It emphasizes the importance of responsible use and legal compliance in exploring the potential benefits of different peptides.

Discover more about the safety of peptides in our blog.

Scientific Research:

[1] Jang J, Park S, Kim Y, Jung J, Lee J, Chang Y, Lee SP, Park BC, Wolfe RR, Choi CS, Kim IY. Myostatin Inhibition-Induced Increase in Muscle Mass and Strength Was Amplified by Resistance Exercise Training, and Dietary Essential Amino Acids Improved Muscle Quality in Mice. Nutrients. 2021 Apr 29;13(5):1508.

[2] Campbell C, McMillan HJ, Mah JK, Tarnopolsky M, Selby K, McClure T, Wilson DM, Sherman ML, Escolar D, Attie KM. Myostatin inhibitor ACE-031 treatment of ambulatory boys with Duchenne muscular dystrophy: Results of a randomized, placebo-controlled clinical trial. Muscle Nerve. 2017 Apr;55(4):458-464.

[3] Bez Batti Angulski A, Hosny N, Cohen H, Martin AA, Hahn D, Bauer J, Metzger JM. Duchenne muscular dystrophy: disease mechanism and therapeutic strategies. Front Physiol. 2023 Jun 26;14:1183101.

[4] Suh J, Lee YS. Myostatin Inhibitors: Panacea or Predicament for Musculoskeletal Disorders? J Bone Metab. 2020 Aug;27(3):151-165.

[5] Smith RC, Lin BK. Myostatin inhibitors as therapies for muscle wasting associated with cancer and other disorders. Curr Opin Support Palliat Care. 2013 Dec;7(4):352-60.

Buy ACE-031 United States Today from PharmaGrade.Store

ALL PRODUCT INFORMATION AND ARTICLES ON THIS SITE ARE FOR EDUCATIONAL PURPOSES ONLY

DISCLAIMER: All products sold by PharmaGrade.Store are for research and laboratory use only. These products are not designed for use or consumption by humans or animals. They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such. By purchasing from our Website the buyer accepts and acknowledges the risks involved with handling of these products. All articles and product information provided on this Website are for informational and educational purposes only. Handling and use of these products should be restricted to suitably qualified professionals